Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28 | $43 | $27 | $17 |
| - Cash | $15 | $20 | $9 | $15 |
| + Debt | $67 | $59 | $42 | $40 |
| Enterprise Value | $79 | $82 | $61 | $43 |
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | -5.3% | -0.4% | 2.2% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 15.9% | 28.8% | 22.6% | 24.8% |
| EBITDA | -$4 | -$10 | -$8 | -$11 |
| % Margin | -154.9% | -341.8% | -272% | -373.9% |
| Net Income | -$10 | -$15 | -$12 | -$14 |
| % Margin | -340.5% | -492.1% | -388.1% | -487.2% |
| EPS Diluted | -0.38 | -0.59 | -0.5 | -0.74 |
| % Growth | 35.6% | -18% | 32.4% | – |
| Operating Cash Flow | -$5 | -$3 | -$8 | -$8 |
| Capital Expenditures | $0 | $0 | -$0 | -$1 |
| Free Cash Flow | -$5 | -$3 | -$8 | -$9 |